SGLT-2 inhibitors Trulicity 240 mg/dL High intensity statin fasting linagliptin <130/80 mmHg every 12 months refrigerator saxagliptin metformin every 3 months carbohydrates sulfonylureas below 7% elderly insulin aspart <70 mg/dL dapagliflozin 5.7% 15g pancreas obesity canagliflozin insulin regular refrigerator 45 degrees insulin pioglitazone 15 minutes TZDs glyburide empagliflozin hepatitis B increased thirst ulcers liraglutide Type 2 Diabetes coronary artery disease basal- once daily glipizide annually twice >10% 6.5% GLP-1 Agonists Type 1 Diabetes nephropathy severe gastroparesis SGLT-2 inhibitors Trulicity 240 mg/dL High intensity statin fasting linagliptin <130/80 mmHg every 12 months refrigerator saxagliptin metformin every 3 months carbohydrates sulfonylureas below 7% elderly insulin aspart <70 mg/dL dapagliflozin 5.7% 15g pancreas obesity canagliflozin insulin regular refrigerator 45 degrees insulin pioglitazone 15 minutes TZDs glyburide empagliflozin hepatitis B increased thirst ulcers liraglutide Type 2 Diabetes coronary artery disease basal- once daily glipizide annually twice >10% 6.5% GLP-1 Agonists Type 1 Diabetes nephropathy severe gastroparesis
(Print) Use this randomly generated list as your call list when playing the game. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.
G-SGLT-2 inhibitors
G-Trulicity
O-240 mg/dL
O-High intensity statin
I-fasting
O-linagliptin
G-<130/80 mmHg
G-every 12 months
I-refrigerator
B-saxagliptin
I-metformin
N-every 3 months
B-carbohydrates
I-sulfonylureas
O-below 7%
I-elderly
G-insulin aspart
B-<70 mg/dL
I-dapagliflozin
O-5.7%
N-15g
G-pancreas
G-obesity
B-canagliflozin
O-insulin regular
B-refrigerator
N-45 degrees
B-insulin
G-pioglitazone
G-15 minutes
I-TZDs
N-glyburide
N-empagliflozin
B-hepatitis B
N-increased thirst
B-ulcers
O-liraglutide
I-Type 2 Diabetes
B-coronary artery disease
N-basal-once daily
O-glipizide
O-annually
G-twice
I->10%
I-6.5%
B-GLP-1 Agonists
N-Type 1 Diabetes
O-nephropathy
N-severe gastroparesis